Table 2.
Author (yr) | Outcome measurement | 3 months | P-value | 12 months | P-value | ||
---|---|---|---|---|---|---|---|
|
|
||||||
Intervention (SD) | Control (SD) | Intervention (SD) | Control (SD) | ||||
Galovski et al21 (1998) | CPSRa | −0.55 (0.53) | 0.32 (0.49) | 0.00047 | NA | NA | NA |
Roberts et al23 (2006) | Full symptom score | −13.00 (10.50) | −4.5 (13.90) | 0.008 | −9.10 (14.00) | −6.40 (14.70) | 0.440 |
Lindfors et al20 (2012) study 1 | GI-symptom questionnaire | −4.50 (8.60) | −0.80 (7.30) | < 0.05 | NA | NA | NA |
Lindfors et al20 (2012) study 2 | GSRS-IBS | −0.43 (0.90) | −0.10 (1.00) | 0.220 | NA | NA | NA |
CPSR was measured at right after end of treatment.
SD, standard deviation; CPSR, composite primary symptom reduction; NA, not allowed; GSRS, gastrointestinal symptom rating scale; IBS, irritable bowel syndrome.